Skip to main content

Latest Market News — Page 122

Page 122 · 30 stories scored 7+ · newest 4:19 PM ET · How scores work

Thu, Aug 1330 stories
9ETONEton Pharmaceuticals, Inc.Eton Pharmaceuticals Q2 EPS Crushes Estimates, Raises 2026 Revenue Guidance to Over $145MEarnings & guidance · Reuters▲ PositivePro7MSAIMultiSensor AI Holdings, Inc.MultiSensor AI Q2 Revenue Jumps 19% to $1.7M, Loss Narrows 26%Earnings & guidance · Reuters▲ Positive7IDNIntellicheck, Inc.Intellicheck Q2 Revenue Beats, But Major Customer Shift Clouds OutlookEarnings & guidance · Reuters● Neutral7DWSNDAWSON GEOPHYSICAL CODawson Geophysical Q2 Revenue Jumps 82% on New Equipment DeploymentEarnings & guidance · Reuters▲ Positive7ICCCImmuCell CorporationImmuCell Q2 Net Income Hits $1.8M on Legal Settlement, Plans $8M Capacity ExpansionEarnings & guidance · Reuters▲ Positive7SLNHSoluna Holdings, IncSoluna Q2 Gross Profit Falls on Briscoe Maintenance, Net Loss Widens to $22.6MEarnings & guidance · Reuters▼ Negative8NMAXNewsmax Inc.Newsmax Posts First Quarterly Profit as Public Company, Revenue Up 16.5%Earnings & guidance · Reuters▲ PositivePro7CNVSCineverse Corp.Cineverse Posts 28-Cent Q1 Loss, Widening From Prior QuarterEarnings & guidance · Dow Jones Newswires▼ Negative7DMRCDigimarc CorpDigimarc Q2 Loss Widens to $12.1M on CEO Transition CostsEarnings & guidance · Reuters▼ Negative7MGNXMACROGENICS INCMacroGenics Q2 Revenue Misses by 51%, But Asset Sale Drives ProfitEarnings & guidance · Reuters● Neutral8SPRYARS Pharmaceuticals, Inc.ARS Pharmaceuticals Doubles Epinephrine Market Share as neffy Revenue ClimbsEarnings & guidance · Reuters● NeutralPro7STNEStoneCo Ltd.StoneCo Q2 Profit Misses Estimates, Revenue Falls ShortEarnings & guidance · Reuters▼ Negative7SESSES AI CorpNYSE Moves to Delist SES AI Warrants Over Low PriceGovernance · Dow Jones Newswires▼ Negative8CRBUCaribou Biosciences, Inc.Caribou's Allogeneic CAR-T Data Rivals Autologous Therapies; Q2 Results Show Cash RunwayEarnings & guidance · GlobeNewswire▲ PositivePro7ELUTELUTIA INC.Elutia Secures $15M Loan to Fund NXT-41x Launch in $1.5B MarketFinancing · GlobeNewswire▲ Positive7MPLTMapLight Therapeutics, Inc.MapLight Reports $351M Cash, Extends Runway Through 2028 After Positive ZEPHYR DataEarnings & guidance · GlobeNewswire▲ Positive7PETSPetMed Express, Inc.PetMeds Q1 Sales Fall 20% to $41M, Loss Narrows to $0.28/ShareEarnings & guidance · GlobeNewswire▼ Negative7VTSIVirTra, IncVirTra Q2 Revenue Falls 17% to $5.8M, Six-Month Loss Widens to $1.6MEarnings & guidance · GlobeNewswire▼ Negative7BLNEBeeline Holdings, Inc.Beeline Q2 Revenue Jumps 57% to $2.6M, Loss Narrows; CEO Adds $500K at Above-Market PriceEarnings & guidance · GlobeNewswire▲ Positive9MGRXMangoceuticals, Inc.Nuclea Energy to Acquire Moltex's Advanced Nuclear Tech Assets in Cash DealM&A & partnerships · GlobeNewswire▲ PositivePro7SWMRSwarmer, IncSwarmer Q2 Revenue Up 57% but Net Loss Widens to $7.3MEarnings & guidance · GlobeNewswire▼ Negative8ROCRank One Computing CorpROC Revenue Doubles Sequentially to $5.1M, Gross Margin Hits 90%Earnings & guidance · GlobeNewswire▲ PositivePro7HGBLHeritage Global Inc.Heritage Global Posts $15.9M Q2 Loss Amid Specialty Lending Wind-DownEarnings & guidance · Dow Jones Newswires▼ Negative7XBPXBP Global Holdings, Inc.XBP Global Posts $1.42 Q2 Loss Per Share, Deepening Financial DistressEarnings & guidance · Dow Jones Newswires▼ Negative8AMATAPPLIED MATERIALS INCApplied Materials Guides 4Q Revenue to $10.25B, Above ConsensusEarnings & guidance · Dow Jones Newswires▲ PositivePro8BAFNBayFirst Financial Corp.BayFirst Posts $8.05 Q1 Loss Per Share After RestatementEarnings & guidance · Dow Jones Newswires▼ NegativePro8GOSSGossamer Bio, Inc.Gossamer Bio Reacquires Seralutinib Rights, Plans September NDA After FDA MeetingEarnings & guidance · BusinessWire▲ PositivePro7CODXCo-Diagnostics, Inc.Co-Diagnostics Posts $1.46 Q2 Loss Per ShareEarnings & guidance · Dow Jones Newswires▼ Negative7SMSISMITH MICRO SOFTWARE, INC.Smith Micro Q2 Loss Narrows to $2.7M, Revenue Grows SequentiallyEarnings & guidance · BusinessWire▲ Positive7ZTSZoetis Inc.FDA Grants Emergency Use Authorization for Zoetis' Simparica Trio Against New World ScrewwormProduct & regulatory · BusinessWire▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.